Metalert (MLRT) AI Stock Analysis

• Market Cap: $1.56M
• Dividend Yield: N/A
• Average Volume (3M): 71.02K
• Price to Earnings (P/E): ―
• Beta (1Y): -6.22
• Revenue Growth: -23.10%
• EPS Growth: 67.19%
• Country: US
• Employees: 8
• Sector: Technology
• Sector Strength: 40
• Industry: Communication Equipment
• EPS (TTM): -0.03
• Shares Outstanding: 34,745,930
• 10 Day Avg. Volume: 68,776
• 30 Day Avg. Volume: 71,022
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 3.09
• Price to Cash Flow (P/CF): -1.70
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

The overall stock score for MLRT is very low, primarily due to its severe financial distress, including negative profitability and high leverage. The technical indicators also point to a bearish trend, further weighing on the stock's outlook. The valuation metrics provide no relief, with a negative P/E ratio and no dividend yield. Significant risks are present, and the company requires substantial changes to improve its financial standing.

Metalert Business Overview & Revenue Model

Company Description

Metalert (MLRT) is a technology company specializing in advanced alert systems and monitoring solutions. The company operates primarily in the sectors of healthcare technology and safety services, offering a range of products and services designed to enhance patient safety and monitoring. Metalert's core offerings include wearable devices and software platforms that provide real-time alerts and data analytics for healthcare providers and caregivers, ensuring timely intervention and improved patient outcomes.

How the Company Makes Money

Metalert generates revenue through a combination of product sales, subscription services, and partnerships. The company sells its wearable devices directly to healthcare facilities, caregivers, and individuals, generating income from the initial purchase. Additionally, Metalert offers subscription-based services for its software platforms, which provide ongoing data analytics, support, and updates. These subscription services are a recurring revenue stream, contributing to the company's financial stability. Furthermore, Metalert has strategic partnerships with healthcare organizations and technology firms that help expand its market reach and integrate its solutions into larger healthcare systems, enhancing its revenue potential.

Metalert Financial Statement Overview

Summary

Metalert is facing severe financial challenges, with negative profitability, high leverage, and poor cash flow management. The company's declining revenue, negative equity, and substantial debt pose significant risks. Urgent strategic and operational changes are needed to stabilize the financial position and drive sustainable growth.

Income Statement

The company shows declining revenue with a significant negative trend in profitability metrics, including gross profit margin and net profit margin. The TTM (Trailing-Twelve-Months) data indicates a gross profit margin of -69.53% and a net profit margin of -488.06%, highlighting severe operational challenges. Revenue has decreased consistently over the years, with a recent decline of 25.28% from the previous year, reflecting a challenging market environment or operational inefficiencies.

Balance Sheet

The balance sheet is weak, characterized by a negative stockholders' equity, indicating insolvency. The debt-to-equity ratio is not calculable due to negative equity, but the high total debt of 6.36 times the total assets is concerning. The equity ratio is -824.62% for the TTM, showing a heavily leveraged position, which poses significant financial risk.

Cash Flow

The cash flow statement exhibits persistent negative operating cash flow, with a TTM figure of -458,253. Free cash flow remains negative, though there is a modest improvement in the free cash flow growth rate. The operating cash flow to net income ratio is 0.51, indicating some alignment between cash flow and earnings, but overall cash management is poor, reflecting liquidity challenges.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
185.57K	248.33K	334.61K	589.44K	1.06M	1.50M
	Gross Profit
-129.03K	21.44K	144.85K	255.25K	460.31K	1.31M
	EBIT
-660.88K	-876.93K	-1.37M	-904.55K	-627.21K	187.32K
	EBITDA
-572.28K	-780.51K	-1.24M	-1.04M	-269.48K	-267.65K
	Net Income Common Stockholders
-905.70K	-1.19M	-1.50M	-1.20M	-368.41K	-586.33K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
180.57K	69.09K	9.22K	140.81K	81.08K	184.42K
	Total Assets
616.06K	610.20K	163.76K	400.28K	298.17K	312.22K
	Total Debt
0.00	3.15M	2.44M	2.00M	2.02M	2.29M
	Net Debt
-180.57K	3.08M	2.43M	1.86M	1.94M	2.17M
	Total Liabilities
371.91K	4.51M	3.48M	3.28M	3.40M	3.91M
	Stockholders Equity
244.15K	-3.90M	-3.31M	-2.88M	-3.10M	-3.60M
Cash Flow		Free Cash Flow
-463.13K	-417.25K	-510.26K	-597.71K	-556.56K	-140.93K
	Operating Cash Flow
-458.25K	-417.25K	-506.95K	-497.68K	-556.56K	-140.93K
	Investing Cash Flow
-4.88K	42.41K	-3.31K	-98.76K	146.20K	42.78K
	Financing Cash Flow
386.10K	434.74K	380.45K	657.88K	362.07K	153.50K

Metalert Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MLRT, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 54.47 is Neutral, neither overbought nor oversold. The STOCH value of 34.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MLRT.

Metalert Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HSTM	67 Neutral	$951.38M	47.73	5.72%	0.38%	4.51%	32.28%
Sector *	57 Neutral	$18.45B	9.41	-13.97%	2.74%	5.04%	-23.56%
MLRT	21 Underperform	$1.56M	―	21.35%	―	-23.10%	67.19%